CGP-35348

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameCGP-35348
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-Aminobutyric Acid B Receptor antagonists
TargetsGamma-Aminobutyric Acid B Receptor
Therapy Area/IndicationsCognition DisordersEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsCognition DisordersEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A